[HTML][HTML] The state-of-the-art of phase II/III clinical trials for targeted pancreatic cancer therapies

A Garcia-Sampedro, G Gaggia, A Ney… - Journal of Clinical …, 2021 - mdpi.com
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies.

A Garcia-Sampedro, G Gaggia, A Ney… - Journal of Clinical …, 2021 - search.ebscohost.com
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

A Garcia-Sampedro, G Gaggia, A Ney… - Journal of Clinical …, 2021 - discovery.ucl.ac.uk
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

[HTML][HTML] The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

A Garcia-Sampedro, G Gaggia, A Ney… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies.

A Garcia-Sampedro, G Gaggia, A Ney… - Journal of Clinical …, 2021 - europepmc.org
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

[PDF][PDF] The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

A Garcia-Sampedro, G Gaggia, A Ney, I Mahamed… - J. Clin. Med, 2021 - core.ac.uk
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

A Garcia-Sampedro, G Gaggia, A Ney… - Journal of Clinical …, 2021 - search.proquest.com
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

[PDF][PDF] The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

A Garcia-Sampedro, G Gaggia, A Ney, I Mahamed… - J. Clin. Med, 2021 - researchgate.net
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

[PDF][PDF] The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

A Garcia-Sampedro, G Gaggia, A Ney, I Mahamed… - J. Clin. Med, 2021 - academia.edu
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …

[PDF][PDF] The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

A Garcia-Sampedro, G Gaggia, A Ney, I Mahamed… - J. Clin. Med, 2021 - scienceopen.com
Pancreatic cancer is a devastating disease with very poor prognosis. Currently, surgery
followed by adjuvant chemotherapy represents the only curative option which, unfortunately …